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It is well-known that DNA-damaging agents induce genome instability, but only recently
have we begun to appreciate that chromosomes are fragile per se and frequently subject
to DNA breakage. DNA replication further magniﬁes such fragility, because it leads to
accumulation of single-stranded DNA. Recent ﬁndings suggest that chromosome fragility
is similarly increased during transcription. Transcripts produced by RNA polymerase II
(RNAPII) are subject to multiple processing steps, including maturation of 5′ and 3′ ends
and splicing, followed by transport to the cytoplasm. RNA maturation starts on nascent
transcripts and is mediated by a number of diverse proteins and ribonucleoprotein particles
some of which are recruited cotranscriptionally through interactions with the carboxy-
terminal domain of RNAPII. This coupling is thought to maximize efﬁciency of pre-mRNA
maturation and directly impacts the choice of alternative splice sites. Mounting evidence
suggests that lack of coordination among different RNA maturation steps, by perturbing
the interaction of nascent transcripts with the DNA template, has deleterious effects on
genome stability. Thus, in the absence of proper surveillance mechanisms, transcription
could be a major source of DNA damage in cancer. Recent high-throughput screenings
in human cells and budding yeast have identiﬁed several factors implicated in RNA
metabolism that are targets of DNA damage checkpoint kinases: ATM (ataxia telangiectasia
mutated) and ATR (ATM-Rad3 related) (Tel1 and Mec1 in budding yeast, respectively).
Moreover, inactivation of various RNA processing factors induces accumulation of γH2AX
foci, an early sign of DNA damage. Thus, a complex network is emerging that links DNA
repair and RNA metabolism. In this review we provide a comprehensive overview of the
role played by pre-mRNA processing factors in the cell response to DNA damage and in
the maintenance of genome stability.
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Mounting evidence collected over the last few years supports
the idea that RNA-binding proteins (RBPs) involved in differ-
ent steps of mRNA life, from transcription to translation, can
affect genome stability programs (Matsuoka et al., 2007; Paulsen
et al., 2009; Hurov et al., 2010). In particular, a number of large-
scale genetic and proteomic quests for proteins involved in the
DNA damage response (DDR) have revealed enrichment in RNA
processing proteins, indicating that RNA metabolism and DNA
repair pathways functionally intersect. However, the role played
by mRNA processing factors in the cell response to endoge-
nous and exogenous sources of DNA damage is still largely
unexplored.
In this review, after a short introduction on the basic principles
of pre-mRNA splicing, we will discuss genome-wide approaches
implicating RBPs in the DDR. Thereafter, we focus on three
particular aspects:
1) RNA-binding proteins may affect the splicing proﬁles and lev-
els of mRNAs for proteins involved in the cell response to
DNA damage. In this section, we address important facets
such as (i) the role of splicing in apoptosis; (ii) the redis-
tribution of splicing factors as a strategy to control splicing
programs after DNA damage; (iii) the modulation of mRNA
stability; (iv) the importance of cotranscriptional splicing, and
(v) post-translational modiﬁcations of RBPs in the DDR.
2) RNA-binding proteins may directly participate in the DDR.
A few examples will be provided to illustrate this still poorly
understood phenomenon.
3) RNA-binding proteins may prevent DNA damage. Once pre-
mRNA has been transcribed, it is processed into mature
ribonucleoprotein (mRNP) particles. In this section, we discuss
the role of mRNP biogenesis factors in preventing hazardous
R-loops.
Finally, we speculate on the potential role that RBPs may play
in the effect of programmed DNA damage on cell differentiation,
a poorly understood subject.
PRE-mRNA PROCESSING
Themajority of metazoan genes consist of anordered successionof
coding (exon) and non-coding (intron) sequences. The generation
of translatable mRNAs requires the precise removal of intronic
sequences via a complex multistep reaction known as splicing.
This reaction is carried out by the spliceosome, a large molecu-
lar machine, composed of ﬁve small nuclear ribonucleoproteins
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(snRNPs U1, U2, U4, U5, and U6) and more than 100 differ-
ent polypeptides (Wahl et al., 2009). The spliceosome recognizes
short, poorly conserved, cis-acting sequence elements at exon–
intron boundaries (5′ and 3′ splice sites) and uses these to remove
the intron through two sequential trans-esteriﬁcations. Alternative
splicing events, using various combinations of donor and acceptor
sites fromdifferent exons, producemore thanonemRNAmolecule
from a single pre-mRNA. Five distinct alternative splicing pat-
terns have been observed: (1) cassette exons, which may be either
selected or skipped during the generation of mRNA; (2) mutu-
ally exclusive exons; (3) intron retained; (4) alternative donor,
and (5) acceptor sites which alter the length of exons. Moreover,
alternative promoters and poly-adenylation sites contribute to the
heterogeneity of transcripts encoded by a single gene (Ghigna
et al., 2008). In addition to modifying protein features, alternative
splicing can also affect the stability of transcripts by introduc-
ing premature STOP codons, thus directing mRNA degradation
through the non-sense-mediated mRNA decay (NMD) pathway
(Maquat and Carmichael, 2001). This regulatory mechanism fre-
quently operates to control the homeostatic level of genes encoding
most RBPs, particularly splicing regulators (Valacca et al., 2010).
Alternatively spliced exons are usually ﬂanked by short and degen-
erate splice sites, and their recognition is modulated by regulatory
sequences referred to as enhancers and silencers of splicing that
respectively promote and inhibit exon recognition. These elements
are present bothwithin exons (ESEs, exonic splicing enhancers and
ESSs, exonic splicing silencers) and introns (ISEs, intronic splic-
ing enhancers and ISSs, intronic splicing silencers; Black, 2003).
Enhancers function by providing binding sites for serine–arginine
(SR) factors, a family (about a dozen) of essential and abun-
dant RBPs highly conserved in evolution (Cartegni et al., 2002).
SR factors display multiple roles in constitutive and alternative
splicing, as well as in other aspects of gene expression (Hastings
and Krainer, 2001). They share a modular structure consisting
of one or two copies of an RNA-recognition motif (RRM) at the
N-terminus followed by a carboxy-terminal domain of variable
length rich in alternating SR dipeptides (the RS domain). The
RRMs determine RNA-binding speciﬁcity, whereas the RS domain
mainly mediates speciﬁc protein–protein interactions that are
essential for the recruitment of the splicing apparatus. In addition,
RS domains are targets of phosphorylation events that inﬂuence
protein interactions (Xiao and Manley, 1998), and regulate the
activity and subcellular distribution of SR proteins (Gui et al.,
1994; see Figure 1). Several kinases, including SR protein kinases
(SRPKs) 1 and 2, Clk/Sty, dual-speciﬁcity tyrosine-regulated
kinase, DNA topoisomerase I (Topo I), glycogen synthase kinase-3
and AKT/Protein Kinase B, have been shown to phosphorylate SR
proteins (for a review see Ghigna et al., 2008). However, the signal
transduction pathways that regulate the activity of these kinases
and their role in alternative splicing are still poorly understood.
Splicing silencers may act as binding sites for factors that block
splicingmachinery access to a splice site. Proteins that interactwith
silencer elements include heterogeneous nuclear ribonucleopro-
teins (hnRNP),a groupof RBPs that interactwithRNApolymerase
II (RNAPII) transcripts to form hnRNP particles (Black, 2003).
Similar to SR factors, hnRNP proteins have a modular struc-
ture in which one or more RNA binding domains, generally at
FIGURE 1 | Phosphorylation controls the subcellular distribution of
splicing factor SRSF1.The arginine–serine (RS)-rich domain of the SR
protein SRSF1 is phosphorylated by SR protein kinases SRPK and Clk/Sty.
The docking motif (DM) restricts phosphorylation of SRSF1 by SRPK1 at the
N-terminal portion of the RS domain (RS1), which is required for the
interaction with transportin SR and nuclear import. In the nucleus, SRSF1
accumulates in nuclear speckles. Clk/Sty causes release of SRSF1 from
speckles by phosphorylating the C-terminal portion of its RS domain (RS2;
Ngo et al., 2005).
the N-terminus, are associated with different “auxiliary” domains.
Three types of RNA binding domains (RRMs, hnRNP K homol-
ogy – KH – domain and RGG domain, a protein region rich in
Arg-Gly-Gly) have been described; these provide a certain level
of RNA binding speciﬁcity (Black, 2003). The auxiliary domains
are very different in sequence and control the subcellular local-
ization and interaction with other proteins. Altogether, RNA
binding speciﬁcity and protein–protein interactions contribute
to the cotranscriptional assembly of hnRNP complexes that are
the substrates of the splicing reaction. In addition to SR fac-
tors and hnRNP proteins, a number of tissue-speciﬁc splicing
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regulators have been identiﬁed some of which, i.e., RNA bind-
ing protein fox-1 homolog (C.elegans) 1 and 2 (RBFOX1 and 2)
and neuro-oncological ventral antigen (NOVA), bind to speciﬁc
RNA sequence elements (Black, 2003).
The vast majority of alternative splicing events are controlled
by the relative abundance and/or activity of widely expressed
antagonistic SR factors and hnRNP proteins through a combi-
natorial mechanism, with multiple positive and negative factors
and sequence elements inﬂuencing the ﬁnal outcome of the splic-
ing reaction. A classical example is the antagonistic activity of
SRSF1 (serine/arginine-rich splicing factor 1), an SR factor, and
hnRNP A1: high levels of SRSF1 induce exon inclusion, whereas
high levels of hnRNP A1 promote exon skipping (Cáceres et al.,
1994). Recent studies indicate that signaling pathways may control
splicing decisions by affecting the subcellular distribution and/or
activity of splicing regulators (Shultz et al., 2010). Many SR fac-
tors andhnRNPproteins continuously and rapidly shuttle between
the nucleus and the cytoplasm (Cáceres et al., 1998), which reﬂects
their involvement in several aspects of RNA life from transcription
to translation.
Alternative splicing is a highly pervasive mechanism of gene
expression regulation that affects the vast majority (more than
90%) of human genes (Pan et al., 2008). It is not surprising, there-
fore, that also transcripts encoding factors involved in the DDR,
checkpoint or apoptosis undergo alternative splicing events that
affect protein function in response to conditions of stress. How-
ever, very few genome-wide analyses on the effects of DNAdamage
on splicing proﬁles have been performed to date and we still have
a very fragmented view of the logic underling this regulatory
mechanism. For instance, only recently the ﬁrst comprehensive
characterization of human transcriptome changes occurring in
response to ionizing radiation (IR) in human lymphoblastoid cell
lines was reported (Sprung et al., 2011).
LARGE-SCALE GENETIC AND PROTEOMIC ANALYSES
Several unbiased large-scale genetic and proteomic screenings in
the last few years have revealed a connection between pre-mRNA
processing and genome stability programs. For instance, a pro-
teomic analysis designed to identify human and mouse proteins
phosphorylated in response to DNA damage on ATM (ataxia
telangiectasia mutated) and ATR (ATM-Rad3 related) consensus
sites, revealed about 700 targets. Most of these belong to pathways
not previously implicated in the response to DNA damage, and
include factors with a role in RNA metabolism. The list of vali-
dated targets includes RBM10 (RNA binding motif protein 10),
which associates with hnRNP complexes and is required for phos-
phorylation of the histone variant H2AX after IR (Matsuoka et al.,
2007). A similar screening in yeast (Smolka et al., 2007) led to the
identiﬁcation of nuclear protein localization 3 (Npl3), a protein
related to human SRSF1 and hnRNP A1, which is also involved
in mRNA export to the cytoplasm. In the same assay, another
splicing factor, called PRP19, was identiﬁed which has a direct
role both in the DDR and in preventing DNA damage induced by
transcription.
Another proteomic analysis quantiﬁed DNA damage-regulated
changes in phosphoproteome, acetylome, and proteome in human
osteosarcoma cells treated with etoposide, a topoisomerase II
(Topo II) inhibitor that causes double-stranded DNA breaks
(DSBs; Beli et al., 2012). Also in this case a signiﬁcant fraction
of the hits corresponded to proteins involved in RNA metabolism.
The same authors focused on the RNA processing factor THRAP3
(thyroid hormone receptor-associated protein 3), which is part
of a multiprotein complex that controls Cyclin D1 mRNA stabil-
ity, and the splicing-regulator phosphatase protein phosphatase
Mg2+/Mn2+ dependent 1G (PPM1G), a nuclear member of
the PP2C family of Ser/Thr phosphatases. Phosphorylation of
THRAP3 mainly depends on the activity of ATR and is elicited
by various DNA-damaging agents and by the DNA replication
inhibitor hydroxyurea. Importantly, THRAP3 down-regulation
makes cells more sensitive to fork stalling, but the molecular
mechanism underlying this effect is still undeﬁned. The lack of
colocalization with γH2AX foci suggests that THRAP3 may play
an indirect role in the DDR, for instance, by regulating alternative
splicing or mRNA stability of transcripts for proteins involved in
DDR, checkpoints or cell cycle progression.
The notion that RNA processing and DNA repair function-
ally intersect has been recently bolstered by a genome-wide small
interferingRNA (siRNA)-based screening for regulators of homol-
ogous recombination (HR; Adamson et al., 2012). This study
identiﬁed a number of pre-mRNAprocessing proteins among pos-
itive regulators of HR, while phosphatase networks were included
in the list of negative regulators.
Finally, a genome-wide approach was applied byYves Pommier
and colleagues to study the effect of the Topo I inhibitor camp-
tothecin (CPT) on splicing decisions in human colon carcinoma
HCT116 and breast carcinoma MCF7 cells. CPT preferentially
affects splicing of transcripts for splicing factors, such as RBM8A,
which belongs to the protein complex that tags exon–exon junc-
tions after the splicing reaction (Solier et al., 2010). Interestingly,
they showed that the production of theTopo I–DNAcleavage com-
plex – Top1cc – triggered by CPT slows down RNA elongation
through the rapid hyperphosphorylation of RNAPII and affects
splicing proﬁles. The effect on the elongation rate of RNAPII
and splicing programs appears to be an outcome shared with
other DNA-damaging agents, such as ultraviolet (UV) irradiation
(Muñoz et al., 2009). Two alternative models have been proposed
to explain the link between the RNAPII elongation rate and splic-
ing programs. In the “kinetic coupling model” a slow RNAPII
may favor the usage of weak splice sites (de la Mata et al., 2010;
Figure 2). Alternatively, hyperphosphorylation of the CTD of
RNAPII may affect the recruitment of splicing factors to the tran-
scriptional machinery as proposed in the “recruitment coupling
model” (Listerman et al., 2006).
RBPs MAY AFFECT THE SPLICING PROFILES AND LEVELS OF
mRNAs FOR FACTORS INVOLVED IN THE CELL RESPONSE TO
DNA DAMAGE
SPLICING AND APOPTOSIS
A large amount of evidence implicates splicing decisions in the
choice between cell survival and apoptosis in response to DNA
damage. The functional consequence of alternative splicing on
apoptosis has been documented for many genes, including cell
surface receptors, such as Fas; adaptor proteins and regulators,
including TRAF2 (TNF receptor-associated factor 2) and APAF-1
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FIGURE 2 | DNA damage affects splicing decisions by modulating the
phosphorylation status of RNAPII and the elongation rate of
transcription. CPT-inducedTop1ccs have immediate and speciﬁc effects on
RNAPII. CPT triggers a high degree of phosphorylation of the largest
subunit (Rpb1) of RNAPII (Baranello et al., 2010). Ultraviolet (UV) irradiation
affects cotranscriptional alternative splicing in a p53-independent manner,
through hyperphosphorylation of the RNAPII carboxy-terminal domain (CTD)
and subsequent inhibition of transcriptional elongation (Muñoz et al., 2009).
(apoptotic protease activating factor 1); mediators, such as B-cell
lymphoma-extra (Bcl-x), Bcl-2 homologous antagonistic/killer
(Bak), andmyeloid cell leukemia sequence 1 (Mcl-1); and caspases.
Remarkably, mRNAs encoding some members of the Bcl2 family
of apoptotic factors, Bcl-x and Mcl-1, are alternatively spliced to
yield both large (L) anti-apoptotic and short (S) pro-apoptotic
forms. The choice between these alternatives has been investi-
gated in several studies that reported the identiﬁcation of relevant
sequence elements and RBPs (reviewed in Moore et al., 2010).
Among the known inducers of apoptosis, Ceramide was the
ﬁrst one shown to control splicing of transcripts encoding mem-
bers of the Bcl-2 (B-cell CLL/lymphoma 2) family and caspase
9. Ceramide treatment increases the level of pro-apoptotic splice
variants Bcl-x(S) and caspase 9a, with a concomitant loss in
the anti-apoptotic Bcl-x(L) and caspase 9b isoforms. This effect
involves the regulation of the phosphorylation status of SR splicing
factors, including SRSF1 (Massiello and Chalfant, 2006), through
activation of PP1 phosphatase (Chalfant et al., 2002). The impor-
tance of SRSF1 phosphorylation in splicing of caspase 9 transcripts
is indicated also by the observation that post-translational modiﬁ-
cation of this factor by the signaling kinase AKT promotes caspase
9b production (Shultz et al., 2010).
Insights into the molecular mechanisms that control these
splicing events came from the analysis of the response to the
genotoxic stress induced by oxaliplatin. This compound elicits an
ATM-, CHK2 (checkpoint kinase 2)-, and p53-dependent splicing
switch that favors the production of the pro-apoptotic Bcl-x(S)
variant and acts through a regulatory sequence element called
SB1. Surprisingly, the same SB1 element mediates the accumula-
tion of the larger anti-apoptotic Bcl-x(L) isoform upon activation
of the PKC pathway. Thus, one splicing regulatory module can
receive antagonistic signals from the PKC and the p53-dependent
DNAdamage response pathways to control the balance of pro- and
anti-apoptotic Bcl-x splice variants (Shkreta et al., 2011) underlin-
ing the complexity of the regulatory circuits that orchestrate the
cell response to conditions of stress.
In a landmark paper, Pamela Silver applied a genome scale
siRNA screening to search for new regulators of Bcl-2 pre-mRNA
splicing. The list of regulators identiﬁed by this screening appears
to be enriched not only for splicing but also for cell cycle functions.
Interestingly, treatments that inducemitotic arrest by targeting the
mitotic aurora kinase A(AURKA) kinase promote the coordinated
pro-apoptotic splicing of Bcl-x, Mcl1, and caspase-9 suggesting
the existence of an alternative splicing network that links cell cycle
control to apoptosis. Upon AURKA knockdown or inhibition,
only splicing factor SRSF1 was down-regulated, most likely via
modulation of post-translational turnover (Moore et al., 2010).
Notably, the SRSF1 function as an inhibitor of apoptotic pathways
and promoter of cell survival is in line with the oncogenic poten-
tial of this splicing regulator (Karni et al., 2007). Collectively these
analyses indicate that perturbations of the post-translationalmod-
iﬁcation proﬁle and expression level of SRSF1 may impact Bcl-2
pre-mRNA resulting in the production of pro-apoptotic isoforms
(Moore et al., 2010).
REDISTRIBUTION OF SPLICING FACTORS
Although SR splicing factors and hnRNP proteins are commonly
considered nuclear proteins most of them continuously shuttle
between the nucleus and the cytoplasm, a property that reﬂects
their role both in mRNA export and in translation (Weighardt
et al., 1995; Cáceres et al., 1998). Nuclear re-import requires the
interaction with dedicated import proteins and in the case of
SR factors depends on the phosphorylation of speciﬁc residues
in the RS domain by SRPK1 and 2 kinases (Figure 1). In addi-
tion to being distributed throughout the nucleoplasm, SR factors
display a characteristic accumulation in highly dynamic nuclear
sub-compartments known as splicing speckles that are viewed
as depots for proteins involved in splicing. Phosphorylation by
Clk/Sty mobilizes SR factors from nuclear speckles to the nucle-
oplasm where transcription and mRNA maturation occurs in the
perichromatin compartment (Biamonti and Caceres, 2009). One
of the strategies exploited by the cells to modulate splicing deci-
sions in response to stress conditions, including DNA damage, is
the redistribution of splicing factors. We signiﬁcantly contributed
to the identiﬁcation of this strategy by showing that heat shock,
heavy metals and osmotic stress, which threaten genome integrity,
inﬂuence the sub-nuclear distribution of speciﬁc splicing factors.
We have shown that splicing factors SRSF1, SRSF9, hnRNP K,
Saf-B (scaffold attachment factor B), and Sam68 (Src-associated
substrate in mitosis of 68 kDa) are recruited to transcription
sites of repetitive genomic DNA in areas called nuclear stress
bodies (Biamonti and Vourc’h, 2010). Osmotic stress also pro-
duces the accumulation of a subset of hnRNP proteins, including
hnRNP A1, into cytoplasmic stress granules. This involves the
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phosphorylation of hnRNP A1 by the Mnk1/2 protein kinases
that act in the p38 stress-signaling pathway (Guil et al., 2006; Bia-
monti and Caceres, 2009). Another example of the stress effect on
cellular distribution of splicing factors is hSlu7, which plays an
important role in 3′ splice site selection during the second step of
splicing in vitro. It has been shown that UV irradiation decreases
the nuclear concentration of hSlu7 through the modulation of its
nucleus-to-cytoplasm transport. This shift is mostly dependent
on the Jun N-terminal kinase cascade. Moreover, the nuclear con-
centration of hSlu7 affects exon choice and alternative splicing
programs (Shomron et al., 2005). More recently it was shown that
mitoxantrone, a Topo II inhibitor, induces relocalization of sev-
eral RBPs, such as TIA-1, hnRNP A1, SRSF1, and SRSF2, from
the nucleoplasm to nuclear granules that serve as transcriptional
factories, even though the identity of the transcribed genes has
not yet been deﬁned. This redistribution is independent of signal
transduction pathways activated by DNA damage and is accom-
panied by changes in the alternative splicing programs of target
genes such as antigen (CD44; Busà et al., 2010). Numerous other
RBPs have been reported to change their distribution in response
to a variety of stress conditions; however, themechanisms involved
in these redistributions have not been investigated. Thus, we still
have a very superﬁcial and fragmented description of this reg-
ulatory strategy that could be part of the cell response to DNA
damage.
MODULATION OF mRNA STABILITY PROGRAMS
DNAdamage elicits the activationof signaling networks, identiﬁed
by apical kinases ATM and ATR, leading to the rapid phosphory-
lation of a large set of cellular proteins. The ultimate function
is to produce an immediate arrest of the cell cycle along with
recruitment of the repair machinery to damaged DNA. The list
of targets for these signaling pathways also includes transcription
factors, in particular p53, whose activation drives a delayed tran-
scriptional response aimed at promoting cell cycle arrest through
the induction of Cdk (cyclin-dependent kinase) inhibitors, i.e.,
p21, and which presides over the choice between cell survival and
apoptotic pathways. A number of studies have recently identi-
ﬁed a third intermediate branch of the DDR that operates on
post-transcriptional regulatory circuits such as alternative splicing
and mRNA stability programs. In this branch, RBPs would serve
both as targets of the signaling network elicited by DNA dam-
age and as transducers of signals to downstream gene expression
programs.
A signiﬁcant fraction of mRNAs is either up- or down-
regulated after cell exposure to IR, UV, or treatment with MMS
(methylmethane sulphonate; Rieger and Chu, 2004). These
changes involve manipulation of mRNA stability through mod-
ulation of the interactions between RBPs and their target mRNA
molecules.
One example is the mRNA encoding the growth arrest- and
DNA damage-inducible GADD45α protein, which is potently
up-regulated in response to stress stimuli. Two RBPs are crit-
ical negative regulators of GADD45α mRNA and protein lev-
els: AUF1, which targets GADD45α mRNA for degradation,
and T-cell-restricted intracellular antigen (TIA) 1-related pro-
tein (TIAR), which prevents the association of GADD45α mRNA
with translating polysomes. The interaction of these two pro-
teins with the 3′-untranslated region (UTR) of the GADD45α
mRNA in HeLa cells drastically decreases after exposure to UV
or treatment with MMS. Crucial for this response is the signal-
ing pathway identiﬁed by p38 and MAPKAP kinase-2 (p38/MK2)
that operates in the cytoplasm downstream of ATM and ATR.
p38/MK2 modulates mRNA stability through phosphorylation
of RNA-binding/regulatory proteins, including hnRNPA0, TIAR,
and polyA-speciﬁc ribonuclease (PARN), and leads to stabiliza-
tion of mRNAs containing AU-rich elements in their 3′-UTR
(Reinhardt et al., 2010).
In addition to GADD45α mRNA, numerous transcripts are
substrates of this regulatory mechanism, a signiﬁcant fraction
of which encodes for proteins relevant to cell cycle control. For
example HuR and hnRNP C1 bind diverse AU-rich elements in
the 3′-UTR of the p21 transcript and function cooperatively to
stabilize p21 mRNA in response to UV, gamma radiation, and
other stress causing treatments (Cho et al., 2010). In contrast, the
PCBP (poly(C)-binding protein) family of RBPs, composed of ﬁve
major members hnRNP K, PCBP1, PCBP2, PCBP3, and PCBP4,
binds CU-rich elements in the 3′-UTR to negatively regulate p21
expression (Waggoner et al., 2009; Scoumanne et al., 2011).
COTRANSCRIPTIONAL PROCESSING AND SPLICING
Many pre-mRNA processing factors are recruited to the RNA
molecule cotranscriptionally through poorly characterized pro-
tein interactions that involve the CTD of RNAPII (Das et al.,
2006). As a consequence, nascent pre-mRNA molecules emerg-
ing from the transcriptional apparatus are immediately assembled
into ribonucleoprotein (RNP) complexes that constitute the sub-
strate of the splicing reaction and determine splicing decisions.
The protein moiety of these complexes depends on several param-
eters such as the sequence speciﬁcity of binding of splicing factors
(in most cases relatively poor) and protein–protein interactions
established among RBPs that are ﬁne-tuned by post-translational
modiﬁcations. Moreover, the modulation of the RBP interactions
with RNAPII and the elongation rate of transcription, have been
shown to play a role in splicing decisions. Although the splicing
reaction does not necessarily occur cotranscriptionally, the cotran-
scriptional recruitment of RBPs may enhance the efﬁciency of the
process.
In a seminal paper published a few years ago,Kornblihtt showed
that UV affects alternative splicing proﬁles in a p53-independent
way. This effect requires the hyperphosphorylation of the CTD
of RNAPII, which leads to inhibition of transcriptional elonga-
tion, a condition known to favor inclusion of alternative exons
by allowing enough time for the usage of weak splice sites (see
Figure 2). Consistently, gene expression analyses with a splicing
sensitive array evidenced a signiﬁcant overlap between gene tran-
scripts undergoing changes in alternative splicing after UV, and
those with reduced expression (Muñoz et al., 2009).
A completely different mechanism of cotranscriptional regula-
tion of splicing proﬁles has been shown to operate in response to
cell treatmentwith theTopo I inhibitorCPT (Dutertre et al., 2010).
Among the 354 exons that are skipped after a short CPT treat-
ment, Auboeuf and colleagues focused on the splicing program of
transcripts for MDM2, an E3 ubiquitin ligase that targets p53 for
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FIGURE 3 | Protein–protein interactions mediate the cotranscriptional
assembly of ribonucleoprotein complexes that are targets of DNA
damage-induced signaling pathways. (A) Schematic representation of
the communication between the transcriptional and splicing machineries
mediated by RPB7, EWS, andYB-1. Camptothecin inhibits the interaction
between Ewing’s sarcoma proto-oncoprotein (EWS), an RNAPII-associated
factor, andYB-1, a spliceosome-associated factor. This results in the
cotranscriptional skipping of several exons of the MDM2 gene (Dutertre
et al., 2010). (B)The PRP19 complex functions in transcription and is
recruited to the transcription machinery by the C terminus of its component
Syf1, the yeast homolog of human XAB2 (adapted from Chanarat et al.,
2011). Human XAB2 co-puriﬁes both with factors involved in transcription
(RNAPII), splicing (PRP19), andTCR (XPA, CSA and CSB; Kuraoka et al.,
2008). The PRP19 complex is required for the recruitment of theTHO/TREX
complex to nascent transcripts after the switch from the B to the C splicing
complex. Thick and thin black lines represent exons and introns,
respectively.
proteasomal degradation. Notably, in addition to CPT, a number
of well-known genotoxic stressors, including doxorubicin and cis-
platin, can promote MDM2 exon skipping (Dutertre et al., 2010).
CPT acts by disrupting the interaction between EWS (Ewing’s sar-
coma proto-oncoprotein), an RNAPII-associated factor, and YB-1
(Y box binding protein 1), a spliceosome-associated factor (see
Figure 3A). This is the ﬁrst demonstration that stress treatment
can alter the communication between transcription and splicing
machineries leading to exon skipping and provides a goodmolecu-
larmodel for the rapid regulation of splicing programs in response
to stress, as shown in yeast (Pleiss et al., 2007).
The EWS protein is a member of the TET family (TLS/FUS,
EWS, and TAF15) of RBPs and DNA-binding proteins, and
functions both in transcription and RNA processing. It is involved
in HR, the DDR, and maintenance of genome integrity and its
knock-out induces a phenotype similar to that observed upon
knock-out of ATM. Furthermore, the EWSR1 (Ewing sarcoma
breakpoint region 1) gene product is important for resistance to IR
(Hurov et al., 2010). Thus, EWS acts as a bridge between transcrip-
tion and splicing machineries: it interacts with proteins involved
in transcription, such as the pre-initiation complex TFIID and
subunits of theRNAPII, andwith splicing factors, including theU1
snRNP protein U1C, the branch-point binding protein BBP/SF1,
and the spliceosome component YB-1 (see references in Dutertre
et al., 2010; Paronetto et al., 2011). UV-light induces dissociation
of EWS from sites of active transcription, and therefore affects the
alternative splicing of genes regulated by this protein such asABL1,
CHK2, and MAP4K2 that are important for the response to cell
stress and DNA damage (Paronetto et al., 2011). This is accom-
panied by the transient enrichment of EWS in nucleoli, which
provides a further example of redistribution of factors as an efﬁ-
cient strategy used by the cells to reprogram gene expression after
treatment with DNA-damaging agents.
POST-TRANSLATIONAL MODIFICATION OF RBPs AND DDR
Recently, we have investigated the cell response to chronic
replication-dependent DNA damage in human DNA ligase I
(LigI)-deﬁcient cells. The LigI defect hampers the maturation
of Okazaki fragments and results in the accumulation of single-
stranded DNA breaks (SSBs) and DSBs and in the constitutive
activation of the ATM checkpoint pathway (Soza et al., 2009). By
applying a proteomic approach, we have shown that the entire set
of SR splicing factors, particularly SRSF1, is hyper-phosphorylated
in LigI-deﬁcient cells and this modiﬁcation is accompanied by a
shift in the alternative splicing program of apoptotic genes such as
caspase 9 (Leva et al., 2012). Notably, both the level of SRSF1 phos-
phorylation and splicing programs can revert to those observed in
normal cells by inhibiting ATM activity, indicating that SRSF1
phosphorylation could be part of a regulatory circuit through
which cells cope with DNA damage. In agreement with this inter-
pretation, SRSF1 phosphorylation is modulated in response to a
wide set of DNA-damaging insults (Leva et al., 2012) and SRSF1 is
involved in the choice between pro- and anti-apoptotic pathways
(Moore et al., 2010).
Phosphorylation of SRSF1 is also relevant to prevention of
DNA damage induced by transcription through a process referred
to as transcription-associated mutagenesis, or TAM, in which
DNA damage preferentially occurs on the non-transcribed strand
of DNA. Moreover, transcription can promote transcription-
associated recombination (TAR), which is largely, but not exclu-
sively (Wahba et al., 2011), due to transcription-replication con-
ﬂicts generated by topological constraints. According to the
twin-domain model (Liu and Wang, 1987), negative and posi-
tive supercoiling domains are transiently generated behind and
ahead, respectively, of the moving transcription complex during
elongation: positive supercoils can impede further DNA unwind-
ing, whereas excessive negative supercoiling favors the opening of
the duplex DNA and facilitates the hybridization of the nascent
RNA molecule to the template giving rise to the so-called R-loops.
One of the factors that prevents the formation of R-loops is Topo
I, which relaxes super-helical stress in duplex DNA. Topo I limits
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R-loop formation by targeting RNA splicing and RNP assembly
factors; particularly SRSF1, which appears to function in the same
pathway as Topo I in preventing replication stress (Tuduri et al.,
2009). The connection between Topo I and SRSF1 was suggested
for the ﬁrst time in 1996 by Jamal Tazi (Rossi et al., 1996) who
identiﬁed Topo I as a speciﬁc kinase for SRSF1. The kinase activity
of Topo I is controlled by poly(ADP-ribose) – PAR – which shifts
Topo I from SRSF1 phosphorylation to DNA cleavage. Interest-
ingly, Topo I, SRSF1, and PAR-polymerase display a high afﬁnity
for the phosphorylated CTD of RNAPII. It has been proposed
that the equilibrium between these factors is relevant both for
the capacity of Topo I to relieve the torsional stress generated by
RNAPII and to phosphorylate SRSF1 engaged in cotranscriptional
splicing events (Malanga et al., 2008). The spacer between the two
RRMs of SRSF1 appears to have an important role in this phe-
nomenon since it controls both phosphorylation of the RS domain
and DNA nicking activity of Topo I. In fact, the spacer is crucial for
the positioning of RRM2 in the cavity normally occupied by DNA
(Ishikawa et al., 2012). It has been proposed that this interaction
may be modulated by other events that involve the spacer, namely
the interaction with the mRNA export factor TAP and the methy-
lation of two arginine residues, a post-translational modiﬁcation
that can also impact the subcellular localization of SRSF1 (Sinha
et al., 2010).
Phosphorylation of SR factors is also relevant to modu-
late the splicing proﬁle of TAF1 in response to DNA damage.
TAF1 is a subunit of the general transcription factor TFIID
and is required for RNAPII activity. Via alternative splicing the
Drosophila melanogaster TAF1 gene produces four mRNAs, TAF1-
1 to 4. Interestingly, both IR and CPT promote the expression
of TAF1-3 and TAF1-4 isoforms. However, the response to IR is
mediated byATMandCHK2,while the effect of CPT requiresATR
andCHK1 (Katzenberger et al., 2006). Themechanismunderlying
this splicing decision is still unidentiﬁed. It has been proposed that
AKT, a protein kinase which plays an important role in cell survival
is involved. ATM mediates full activation of AKT in response to IR
(Viniegra et al., 2005), and in turn AKT regulates the function of
SR splicing factors by phosphorylating the RS domain (Blaustein
et al., 2005).
Another example involves the regulated phosphorylation and
acetylation of the SR protein SRSF2 (also called SC35). Acetyla-
tion on Lys52 in the RRM inhibits RNA binding and promotes
proteasomal degradation. This modiﬁcation is controlled by the
competing activities of the acetyl transferase TIP60 and the
deacetylase HDAC6. DNA-damaging agents such as cisplatin
inhibit TIP60 expression and increase SRSF2 stability. TIP60
also controls nuclear translocation of the SR kinases SRPK1 and
SRPK2, which induce phosphorylation of SR proteins and con-
trol their localization and activity. Thus, cisplatin-induced loss
of TIP60 leads to the accumulation of non-acetylated, phos-
phorylated SRSF2, which in turn promotes the production of
the pro-apoptotic splicing isoform of caspase-8 (Edmond et al.,
2011). This analysis provides an exciting example of how mul-
tiple post-translational modiﬁcations and regulated proteasomal
degradation of a splicing factor cooperate to promote apoptosis in
response to DNA damage. Consistent with its crucial role in the
activation of the apoptotic splicing programof genes such as c-ﬂip,
caspases-8, -9, and Bcl-x, the expression of SRSF2 increases in
response to DNA damage. Interestingly, SRSF1 and SRSF2 appear
to have antagonistic activities with SRSF1 favoring anti-apoptotic
splicing while SRSF2 promotes apoptosis. Consistent with this
interpretation, SRSF2 gene transcription is controlled by E2F1,
which promotes apoptosis through both transcription-dependent
and -independent mechanisms (Merdzhanova et al., 2008).
In addition to phosphorylation, other post-translational mod-
iﬁcations are relevant to activity modulation of RBPs in the DDR.
An example comes from the analysis of hnRNP K, a protein crucial
for IR-induced cell cycle arrest. HnRNP K cooperates with p53 in
transcriptional activation of cell cycle arrest genes such as 14-3-3,
GADD45, and p21, in response to DNA damage (Moumen et al.,
2005). hnRNP K is a substrate of the ubiquitin E3 ligase MDM2
and, upon DNA damage, is de-ubiquitylated and sumoylated on
Lys 422 in the KH3 domain. This modiﬁcation is regulated by the
E3 ligase polycomb Pc2/CBX4 and is required for p53 transcrip-
tional activation. Abrogation of hnRNP K sumoylation leads to
aberrant regulation of the p53 target gene p21 (Lee et al., 2012;
Pelisch et al., 2012). Many other hnRNPs are SUMO substrates
(Vassileva andMatunis, 2004) raising the possibility that thismod-
iﬁcation is important to modulate the activity of RBPs in response
to DNA damage. For instance, sumoylation of hnRNP F could
be relevant to the activity of hnRNP H/F in p53 pre-mRNA 3′-
end processing, protein expression, and p53-mediated apoptosis
(Decorsière et al., 2011).
RBPs MAY DIRECTLY PARTICIPATE IN THE DDR
A few RBPs have a dual life; they are associated both with com-
plexes involved in RNA metabolism and with the DNA repair
machinery. This condition reﬂects the fact that proteins assem-
blies involved in transcription, splicing, andDNArepair frequently
operate on the same tract of a DNA molecule. To date no one
has investigated whether the recruitment of RBPs to the DNA
repair complex is evidence that RNA molecules may play a role in
genome stability programs as recently suggested by the discovery
of short non-coding RNAs complementary to sites of DNA dam-
age (Francia et al., 2012). Below we report a few examples of RBPs
interacting with DNA repair assemblies.
hnRNP G/RBMX
A recent genome-wide screening for regulators of HR (Adamson
et al., 2012) identiﬁed hnRNP G as a positive regulator that tran-
siently accumulates at sites of DNAdamage. This ﬁnding raises the
possibility (shared with other RBPs such as hnRNP C and hnRNP
K) of a direct role in the DDR. The biochemical consequences
of transiently accumulating hnRNP G at sites of damage remains
to be determined. The authors hypothesized that the recruitment
of hnRNP G could help bundle PAR (polyADP-ribose) structures
and hold breaks together.
Ntr1/Spp382
Non-homologous end joining (NHEJ) in mammalian and yeast
cells requires a set of common core factors, including the DNA
end-binding proteins Ku70 (Ku70p) and Ku80 (Ku80p), as well as
the DNA ligase LIG4 (Dnl4p) and its associated factor XRCC4
(Lif1p; Sancar et al., 2004). Recently, it has been shown that
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both human XRCC4 and its yeast homologue Liﬂp interact with
the putatively orthologous G-patch proteins Ntr1p/Spp382p and
NTR1/TFIP11 that have recently been implicated in spliceosome
disassembly (Fourmann et al., 2013). G-patches are short con-
served sequences of about 40 amino acids containing seven highly
conserved glycine residues that have been proposed to medi-
ate RNA binding (Aravind and Koonin, 1999). The interaction
with NTR1 (Ntr1p) prevents the formation of an active enzyme
complex betweenXRCC4 (Lif1p) and LIG4 (Dnl4p) thus reducing
NHEJ efﬁciency (Herrmann et al., 2007).
SFPQ/PSF
SFPQ (splicing factor proline and glutamate-rich), also known
as PSF (polypyrimidine tract-binding protein-associated splic-
ing factor) and its paralogs p54nrb/non-POU domain containing
octamer binding (NONO) and Paraspeckle Component 1-PSPC1
are members of the Drosophila behavior/human splicing (DBHS)
family and components of sub-nuclear bodies called paraspeck-
les (Shav-Tal and Zipori, 2002). SFPQ/PSF has a direct role in
the DDR that involves its ability to bind and modulate the func-
tion of RAD51 a key component of the HR pathway (Rajesh
et al., 2011). Interestingly, SFPQ/PSF has DNA re-annealing and
strand-invasion activity that may lead to the formation of D-loop
structures similar to intermediates observed during HR (Akhme-
dov andLopez,2000). It has not yet been investigated if this protein
can also interact with R-loops, which appear to be deleterious for
genome stability.
SFPQ and its highly similar (71% identity) paralog NONO
form a heterodimer involved in various aspects of RNA
metabolism, such as transcription, pre-mRNA processing, and
transcription termination. They are also implicated in nuclear
retention of hyper-edited RNA (Passon et al., 2012). In this func-
tion they act together with Matrin 3 (MATR3) a highly conserved,
inner nuclear matrix and RBP,which is a target of ATM and CHK1
(Blasius et al., 2011). A SFPQ/NONO complex promotes NHEJ
in vitro, and is probably involved in DSB repair in vertebrates
(Bladen et al., 2005). In agreement with this idea, attenuation of
NONO expression impairs DSB repair and increases radiation-
induced chromosomal aberrations (Li et al., 2009). Moreover,
SFPQ/NONO is rapidly recruited to sites of DNA damage induced
by laser microbeams and its release from these sites is regulated by
MATR3 (Salton et al., 2010).
PRP19
PRP19/PSO4 is a multifunctional protein also known as nuclear
matrix protein 200 NMP200 (Gotzmann et al., 2000), UBOX4 for
its involvement in theubiquitin pathway (Hatakeyama et al., 2001),
and senescence evasion factor SNEV (Grillari et al., 2005). The
PRP19 complex consists of four polypeptides that form a salt-
stable core (CDC5L, PRLG1, Prp19, and SPF27) with three more
loosely associated polypeptides (HSP73, CTNNBL1, and AD002;
Grote et al., 2010). PRP19 is found at the core of catalytically
activated spliceosomes (Grote et al., 2010) and its ubiquitin lig-
ase activity plays a critical role in activation of the spliceosome
(Song et al., 2010).
The ﬁrst indication that PRP19 had a role in the DDR was the
identiﬁcation of the pso4-1 mutant in S. cerevisiae that displays
increased sensitivity to the DNA cross-linking drug psoralen. This
mutant shows defects in some types of recombination, including
gene conversion, crossing over, and intrachromosomal recombi-
nation. It belongs to the RAD52 epistasis group for strand-break
repair and its product participates in the DNA rejoining step of
the repair of cross-link lesions (de Morais et al., 1996). In human
cells, Prp19 is strongly up-regulated in response to DNA damage
and its down-regulation results in DSBs, apoptosis, and reduced
survival after exposure to IR. Moreover, Prp19 is a target of post-
translational modiﬁcations elicited by DNA damage. The human
protein is phosphorylated at S149 byATM in response to oxidative
stress and DSB-inducing agents (Dellago et al., 2012). DNA dam-
age also induces ubiquitination of PSO4 and this modiﬁcation
disrupts the interaction with both CDC5L and PLRG1. Inter-
estingly, in further support of its involvement in the DDR, the
CDC5L subunit of the complex directly interacts with the master
checkpoint kinase ATR (Legerski, 2009).
Recently, PRP19 has been implicated in the transcription-
coupled repair (TCR) pathway,which deals withDNAdamage that
blocks transcription elongation. This activity of PRP19 depends
on the interaction with XAB2 [xeroderma pigmentosum group A
protein (XPA) binding protein 2], a molecular partner of XPA,
that interacts also with Cockayne syndrome group A and B pro-
teins (CSA and CSB) and RNAPII and it is involved both in TCR
and transcription (Kuraoka et al., 2008).
Recent studies have started to uncover the intricacy of interac-
tions between complexes once considered completely unrelated.
Thus, XAB2 (also known as Syf1) mediates the interaction of
PRP19 with RNAPII and is responsible for its role in TCR. In
turn, the PRP19 complex is necessary for the recruitment of the
THO/TREX complex to transcribed genes, which is important
to prevent the formation of R-loops and genome instability. The
spliceosome is a highly dynamic molecular machine that is assem-
bled in a stepwise manner onto the pre-mRNA, leading to the
formation of intermediates called complexes E, A, B, B*, and C
(Wahl et al., 2009). The ﬁrst trans-esteriﬁcation generates the C
complex, which catalyzes the second step of the splicing reaction.
Interestingly, human PRP19 complexes containing XAB2/hSyf1
are present within the B complex, whereas THO/TREX compo-
nents are only present in the C complex (Chanarat et al., 2011; see
Figure 3B).
The role of RBPs in DNA repair is still largely unexplored,
probably because it has been underestimated by scientists work-
ing both in the RNA and DNA repair ﬁelds. However, the list of
RBPs involved in DNA repair or colocalizing with sites of DNA
damage is continuously growing, which clearly points to the exis-
tence of relevant connections between the twoprocesses. In the last
decade, transcription, RNA and RNP complexes have been impli-
cated in epigenetic processes (Burgess et al., 2012). We are tempted
to propose that theymayplay a similar role in the profoundhigher-
order reorganization associated with DNA repair. As a matter of
fact short non-coding RNAs complementary to sequences ﬂank-
ing DSBs have been recently described and shown to control DDR
activation at sites of DNA damage (Francia et al., 2012). Genera-
tion of these RNAs requires the activity of Drosha and Dicer two
ribonucleases involved in the RNAi pathway. However, nothing
is known about the nature and synthesis of the precursor RNA
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molecules. Whether the RBPs listed above may have a role in this
process is an open and intriguing possibility.
RBPS MAY PREVENT DNA DAMAGE
A ROLE FOR mRNP BIOGENESIS FACTORS IN PREVENTING HAZARDOUS
R-LOOPS
A transcriptional R loop is a structure in which a nascent tran-
script is partially or completely hybridized with the template
strand leaving the other strand unpaired (Huertas and Aguilera,
2003). The topology of the template DNA (i.e., accumulation of
negative supercoiling behind the transcriptional apparatus), and
the DNA sequence (i.e., G-richness) signiﬁcantly inﬂuence the
formation and size of RNA–DNA hybrids in in vitro reactions,
suggesting that the capacity to form R-loops is an inherent prop-
erty of the nascent RNA molecule. R-loops are highly mutagenic
structures. The unpaired DNA strand in an R-loop, in fact, is
more sensitive to DNA-damaging agents and nucleases and, as
in the case of B cell immunoglobulin class switching, is targeted
by activation-induced cytidine deaminase (AID)-mediated DNA
cytosine deamination (Gómez-González and Aguilera, 2007).
Moreover, the R-loop is highly recombinogenic and can gener-
ate a block for incoming DNA replication forks or even provide
unscheduled RNA primers for DNA polymerases (Bermejo et al.,
2012; Figure 4).
Because of their negative effects on genome stability, several
mechanisms operate to avoid R-loop formation. First of all, as
indicated by structural studies, the nascent transcript that emerges
from the exit channel of theRNApolymerase has already separated
from the template DNA strand. This also implies that R loops do
not directly extend from the transcription bubble (Westover et al.,
2004). Topoisomerases,mainly Topo I, are active during transcrip-
tion to prevent the accumulation of negative supercoiling behind
the RNAPII that are suitable for R-loop formation. Moreover,
RNaseH activities operate to reduce the level of RNA:DNAhybrids
(Wahba et al., 2011). Finally, the nascent RNA molecule, as soon
as it emerges from the transcriptional apparatus is sequestered
in RNP complexes. How this protein–RNA packaging inﬂuences
the capacity to form R-loops is still a matter of investigation even
if it is commonly assumed that binding to RBPs is alternative to
R-loop formation (Huertas and Aguilera, 2003). Notably, splicing
proteins have been selected in screening performed in mammalian
cells designed to identify factors able to prevent spontaneous DNA
breaks (Paulsen et al., 2009). On the other hand, experimental evi-
dence suggests that R-loops physiologically form within the cells.
Indeed, R-loop structures play physiological roles in immunoglob-
ulin class switch recombination (CSR) in human B cells (Yu et al.,
2003) and in the promotion of transcription termination, as in
the case the human β-actin gene (Skourti-Stathaki et al., 2011).
Moreover they may occur during transcription of very long genes
whose transcription may take more than one cell cycle (Helmrich
et al., 2011).
RNA polymerase II plays a critical role in the processing of
mRNA precursors (pre-mRNA). This involves the interaction
of a large number of factors involved in capping, splicing and
termination/poly-adenylation. The interaction is mediated by
the CTD of RNAPII, which is composed mainly of a repeated
heptapeptide motif, YSPTSPS, that is extensively phosphorylated
FIGURE 4 | Upper panel: the translocation of the transcriptional
apparatus along the DNA induces positive and negative supercoiling,
respectively, in front of and behind RNAPII.The physiological association
of RBPs with the pre-mRNA molecule as it emerges from the
transcriptional machinery is believed to play a major role in counteracting
R-loop formation in negatively super-coiled regions. Middle panel:
hybridization of the nascent RNA with the DNA template results in the
formation of R-loops and occurs upon down-regulation, inhibition or
mutation of several speciﬁc RBPs involved in different steps of pre-mRNA
synthesis/maturation. The list of RBPs that may inﬂuence R-loop formation
includes Capping enzymes, splicing factors SRSF1 and SRSF2, the
THO/TREX complex, and Sen1/senataxin which is important for
transcription termination. Moreover, DNA topoisomerase I (Topo I) by
relieving torsional stress and phosphorylating SRSF1 can prevent R-loop
formation. Bottom panel: R-loops hamper the movement of the DNA
replication fork, which promotes genome instability. Thus, RBPs may be
crucial to genome stability programs by inhibiting R-loop formation.
during the transcription cycle (Schroeder et al., 2000). Phosphory-
lation of serine-5 in the heptad repeats by human Cdk7 and yeast
Kin28, occurs shortly after transcription initiation and is required
for cotranscriptional recruitment of pre-mRNA processing fac-
tors. Several studies have indicated that all these factors may have
a role in preventing the formation of R-loops.
Interestingly, under certain circumstances some of these factors
may actually promote R-loop formation. This is the case of Cap-
ping Enzymes whose interactionwith the transcriptionmachinery
is critical for RNA elongation. In vitro, in the presence of phospho-
rylated CTD, the human Capping enzymes speciﬁcally promote
formation of R-loops. There is no evidence so far that Capping
enzymes are involved in DNA damage. Intriguingly, however,
their in vitro capacity to induce R-loops is antagonized by splicing
factor SRSF1 (Kaneko et al., 2007), whose down-regulation in vivo
promotes R-loop formation leading to DNA fragmentation and
cell death (Li et al., 2005).
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THO/TREX
One of the best-characterized RBP complexes shown to pre-
vent R-loop formation is called THO/TREX. The multimeric
THO/TREX complex is conserved throughout evolution and
human homologues of all the yeast components have been
identiﬁed: hTHO2/THOC2, hHpr1/THOC1, fSAP79/THOC5,
fSAP35/THOC6, fSAP24/THOC7, and hTex1/THOC3, the
DEAD-box RNA helicase Sub2/UAP56 and the mRNA export
adaptor protein Yra1/Aly/THOC4 (Masuda et al., 2005). Both
in yeast and humans the complex is functionally involved in
connecting transcription, mRNP biogenesis and genome instabil-
ity. Its mutation increases R-loop-dependent genome instability,
and in the mouse enhances class-switching recombination in the
immunoglobulin locus (Domínguez-Sánchez et al., 2011). The
analysis ofmutatedTHO/TREX in yeast byAguilera and colleagues
(Huertas and Aguilera, 2003) provided the ﬁrst evidence that
RNA metabolic functions have a role in preventing R-loops and
that these structures mediate both impairment of transcription
elongation and TAR. Using an engineered transcript containing a
hammerhead ribozyme, they showed that the nascent mRNA itself
has a role in the origin of transcription elongation impairment and
genome instability associated with THO mutations. The function
of THO/TREX-2 complexes is to couple RNAPII transcription
(Gómez-González et al., 2011) with mRNA export through the
nuclear envelope, a process known as gene gating. In this way
another topological constraint is superimposed on to DNA dur-
ing the transcription process. TheATR checkpoint phosphorylates
key nucleoporins to counteract gene gating, thus neutralizing
the topological tension generated when forks encounter gated
genes (Bermejo et al., 2011). Mutants in some elements of this
pathway may eventually lead to formation of R-loops and DNA
damage. Thus, one physiological function of factors such as the
THO/TREX-2 complexes would be to prevent R-loop formation
and relieve topological constraints (Bermejo et al., 2012).
THSC COMPLEX
THSC (Thp1-Sac3-Sus1-Cdc31) is another complex that, simi-
lar to THO/TREX, connects transcription elongation to mRNA
export via a RNA-dependent dynamic process. The THSC com-
plex is formed by Thp1, Sac3, and Sus1 Cdc13 subunits and
was previously shown to interact with the SAGA (Spt-Ada-
Gcn5-Acetyltransferase) complex, a histone acetyltransferase.
However, its role in transcription elongation is independent of
SAGA and is linked to mRNA export. It has been proposed
that a feedback mechanism exists by which improperly formed
mRNPs, presumably stacked at the nuclear pore, have a backward
effect promoting transcription impairment and genetic instability
(González-Aguilera et al., 2008).
SPLICING FACTORS OF THE SR FAMILY
In addition to the THO/TREX complex, several mRNP biogene-
sis/export factors, from yeast to humans, cause TARwhenmutated
or down-regulated, even though their effect is weaker than that
observed with THO/TREX mutants (Luna et al., 2005). Genetic
studies in yeast proved that deletions of genes acting at vari-
ous stages of RNA metabolism, from transcription initiation to
RNA degradation and export, increase the rate of instability 4- to
16-fold over wild type (Wahba et al., 2011). In mammals, Man-
ley’s group has clearly proved that a speciﬁc subset of splicing
factors of the SR family, including SRSF1 (Li et al., 2005) SRSF2
and SRSF3, can inhibit the formation of R-loops (Li and Man-
ley, 2005). Thus, errors in RNA processing pose a major threat
to genome integrity. In human and chicken DT40 cells, SRSF1
prevents R-loop formation (Li et al., 2005). A screen for suppres-
sor(s) of SRSF1 depletion-induced genome instability in chicken
DT40 cells identiﬁed RNPS1, a nuclear RBP with multiple roles in
mRNA maturation. The fact that RNPS1 cannot compensate for
SRSF1 function in splicing, suggests that the ability to prevent R-
loops is a distinctive feature of only a few RBPs, which is separate
from their activity in splicing (Li et al., 2007).
It is commonly accepted that R-loops are prevented by speciﬁc
RBPs that facilitate the proper packaging of nascent mRNA into
RNP particles, which in turn would strongly reduce the ability
of the RNA molecule to rehybridize with the transiently opened
DNA strands behind the RNAPII (Huertas and Aguilera, 2003).
However, it is possible that dysfunction of mRNA processing
factors may enhance R-loop formation by increasing RNA half-
life, by blocking transcription elongation and possibly stabilizing
negative supercoiling, or by impairing 3′-end processing and/or
termination that would affect RNA release from the transcription
site. Another major point of discussion concerns the mechanism
through which R-loops favor genome instability. However, the
majority of scientists favor the idea that R-loop-mediated genomic
instability is mainly caused by impairment of replication fork pro-
gression (Tuduri et al., 2009; Gan et al., 2011). Strong support of
this hypothesis comes form the analysis of Sen1/Senataxin.
Sen1/SENATAXIN
Recent data suggest that R-loops may play a physiological function
in transcription termination. Two classes of terminator sequences
have been identiﬁed in human genes: cotranscriptionally cleaved
(CoTC) RNA sequences and transcription pause sites. The latter
correspond to G-rich sequence elements and act to slow down
elongating RNAPII. They have been identiﬁed in several human
genes including the human β-actin gene (Skourti-Stathaki et al.,
2011). Sen1 is a conserved RNA/DNAhelicase known to cooperate
with Xrn2/Rat1 in promoting efﬁcient transcriptional termina-
tion in S. cerevisiae (Kawauchi et al., 2008). This function is
conserved in evolution. Indeed, depletion of human senataxin,
the mammalian Sen1 homolog, increases RNAPII density down-
stream of the poly(A) site and induces R-loop formation. Taking
into account the behavior of the Sen1 mutant in yeast (Mischo
et al., 2011) and the effect of senataxin inactivation in humans
cells at the β-actin gene locus (Skourti-Stathaki et al., 2011), it
has been suggested that in vivo R-loops may be more common
than previously believed and their unwinding by Sen1/senataxin
is physiologically important for transcription termination at tran-
scriptional pause sites. Recent data indicate that pathological
R-loops in Sen1 mutants would induce hyper-recombination via
inhibition of DNA replication. From this viewpoint Sen1 would
be relevant to protect genome integrity from DNA damage result-
ing from the head-on collision of transcription and replication.
This property seems to be linked to the association of Sen1 with
DNA replication forks which is crucial to protect fork integrity
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across RNAPII-transcribed genes (Alzu et al., 2012). A similar role
in preventing replication-transcription conﬂicts was proposed for
human senataxin (Yüce and West, 2013). Finally, as a further
example of the connections between complexes involved in pre-
mRNA synthesis, RNA processing, DNA repair and replication,
Sen1 has been involved also in TCR via an interaction with Rad2,
the yeast homologue of human XPG (xeroderma pigmentosum
complementation group G; Ursic et al., 2004).
PERSPECTIVES
DNA damage induces the activation of signaling pathways that
target the expression and post-translational modiﬁcation of RBPs
involved in the metabolism of protein-coding transcripts. How-
ever, the physiological consequences of these events are far from
being understood even though it is highly probable that targeting
of RBPs may impact gene expression proﬁles. For instance, solid
evidence bolsters the idea that the recruitment of speciﬁc splic-
ing factors, such as SRSF1 and SRSF2, in the DDR can be linked
to the inhibition/activation of apoptotic pathways. An appealing
hypothesis is that this strategy could have a broader effect on gene
expression and cell differentiation programs.
A growing body of data from the last ten years implicates the
DDR in regulating precursor or stem cell differentiation programs
(Sherman et al., 2011). One clear example is the development
of vertebrate adaptive immune systems that requires the pro-
grammed induction and subsequent repair of DSBs during antigen
receptor gene rearrangements to assemble a complete Ig gene via
V(D)J recombination. The response to these programmed DSBs
elicits ATM-dependent and ATM-independent mechanisms that
ultimately control the expression of approximately 300 genes, a
signiﬁcant fraction of which regulates cellular processes important
for lymphocyte development (Bredemeyer et al., 2008). Notably,
several of these genes are regulated in response to genotoxic DNA
damage as well, indicating that unphysiological DSBs disrupt
normal cellular functions by altering speciﬁc gene expression pro-
grams (Bredemeyer et al., 2008). DSBs are also necessary for CSR
and somatic hypermutation (SHM) required for the production
of high-afﬁnity antibodies of different isotypes. During CSR, pro-
duction of DSBs requires the programmed formation of R-loops
(Roy et al., 2008) and deoxycytidine deaminationmediated byAID
(Chaudhuri et al., 2007). The response to DSBs produced by AID
activates an ATM-dependent signaling pathway that regulates a
network of genes involved in proliferation, B-cell self-renewal, and
cell differentiation (Sherman et al., 2010). Interestingly, unsched-
uled AID-mediated DSBs are implicated in cancer (Park, 2012)
even though it is unclear if the link with cancer involves targeting
of aberrant R-loop structures.
DNA damage response may also inﬂuence differentiation of
pluripotent embryonic stem cells (ESCs). DNA lesions in ESCs
could be particularly harmful for the organisms. Thus, apoptotic
pathways may clear severely damaged cells from the replicating
stem cell pools. Alternatively, ESCs can activate a gene expression
program controlled by p53 to promote cell cycle withdrawal and
differentiation (Hong et al., 2009). Two parameters appear to be
crucial to determine the choice between apoptotic vs. differen-
tiation programs. The ﬁrst one is related to the extent of DNA
damage in the sense that apoptosis or senescence is the proper
response to extensive genome-wide damage. A low level of DNA
damage may induce cell differentiation programs as in developing
B cells during Ig gene modiﬁcations. A second decision-regulating
process is linked to the differentiation state of cells that experience
DNA damage. For example, DDR signaling via ATM promotes
the quiescence of stem cells, whereas in more advanced lin-
eage progenitors, such as pre-B (Bredemeyer et al., 2008) cells,
ATM-dependent DDR signaling promotes cell differentiation.
We speculate that, because of their involvement in gene expres-
sion programs, RBPs may have a role in all these decisions.
Moreover, in view of their association with large, still poorly
characterized, multiprotein assemblies that link genome stabil-
ity, transcription, and pre-mRNA processing, RBPs may be crucial
not only for the response to genotoxic stress but also for the pro-
grammed induction of DNA damage during cell differentiation
processes.
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